title: Increased susceptibility of peripheral blood mononuclear cells to equine herpes virus type 1 infection upon mitogen stimulation: a role of the cell cycle and of cell-to-cell transmission of the virus.
abstract: Equine herpesvirus-1 (EHV-1) is an important pathogen of horses, causing abortion and nervous system disorders, even in vaccinated animals. During the cell-associated viremia, EHV-1 is carried by peripheral blood mononuclear cells (PBMC), mainly lymphocytes. In vitro, monocytes are the most important fraction of PBMC in which EHV-1 replicates, however, mitogen stimulation prior to EHV-1 infection increases the percentage of infected lymphocytes. The role of the cell cycle in viral replication and the role of cluster formation in cell-to-cell transmission of the virus were examined in mitogen-stimulated PBMC. Involvement of the cell cycle was examined by stimulating PBMC with ionomycin/phorbol dibutyrate (IONO/PDB) during 0, 12, 24 and 36 h prior to inoculation. Cell cycle distribution at the moment of inoculation and the percentage of EHV-1 antigen-positive PBMC at 0, 12 and 24 hours post inoculation (hpi) were determined by flow cytometry and immunofluorescence microscopy, respectively. The role of clusters was examined by immunofluorescence staining within clusters of stimulated PBMC using antibodies against EHV-1. Significant correlations were found between the increase of cells in the S- or G2/M-phase after a certain time interval of prestimulation and the increase of EHV-1 antigen-positive cells. The percentage of clusters with adjacent infected cells significantly increased from 3.3% at 8 hpi to 23.7% at 24 hpi and the maximal number of adjacent infected cells increased from 2 to 7. Addition of anti-EHV-1 hyperimmune serum did not significantly alter these percentages. Mitogen stimulation favours EHV-1 infection in PBMC by: (i) initiating cell proliferation and (ii) inducing formation of clusters, thereby facilitating direct cell-associated transmission of virus.
authors.affiliation: Faculty of Veterinary Medicine, Laboratory of Virology, Ghent University, Salisburylaan 133, B-9820, Merelbeke, Belgium.
authors.forename: Karen M
authors.initials: KM
authors.lastname: van der Meulen
authors.forename: Hans J
authors.initials: HJ
authors.lastname: Nauwynck
authors.forename: Maurice B
authors.initials: MB
authors.lastname: Pensaert
mesh_terms: D000818:Animals; D000956:Antigens, Viral / Q000032:analysis; D002449:Cell Aggregation / Q000502:physiology; D002453:Cell Cycle / Q000502:physiology; D005434:Flow Cytometry / Q000662:veterinary; D006566:Herpesviridae Infections / Q000097:blood / Q000473:pathology / Q000662:veterinary* / Q000821:virology; D004861:Herpesvirus 1, Equid / Q000254:growth & development*; D006734:Horse Diseases / Q000097:blood / Q000473:pathology / Q000821:virology*; D006736:Horses; D015759:Ionomycin / Q000494:pharmacology; D007476:Ionophores / Q000494:pharmacology; D007963:Leukocytes, Mononuclear / Q000166:cytology / Q000187:drug effects / Q000821:virology*; D008213:Lymphocyte Activation / Q000187:drug effects / Q000502:physiology; D008934:Mitogens / Q000494:pharmacology; D015240:Phorbol 12,13-Dibutyrate / Q000494:pharmacology; D014779:Virus Replication / Q000502:physiology
chemical_list: D000956:Antigens, Viral; D007476:Ionophores; D008934:Mitogens; D015240:Phorbol 12,13-Dibutyrate; D015759:Ionomycin